Logo image of JVSA

JVSPAC ACQUISITION CORP-A (JVSA) Stock Fundamental Analysis

NASDAQ:JVSA - Nasdaq - VGG5212E1051 - Common Stock - Currency: USD

10.8  -0.02 (-0.18%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to JVSA. JVSA was compared to 51 industry peers in the Construction & Engineering industry. While JVSA seems to be doing ok healthwise, there are quite some concerns on its profitability. JVSA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

JVSA had positive earnings in the past year.
In the past year JVSA has reported a negative cash flow from operations.
JVSA Yearly Net Income VS EBIT VS OCF VS FCFJVSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500K -500K 1M 1.5M 2M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.28%, JVSA is in line with its industry, outperforming 54.90% of the companies in the same industry.
JVSA has a Return On Equity (3.30%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 3.28%
ROE 3.3%
ROIC N/A
ROA(3y)-5.71%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JVSA Yearly ROA, ROE, ROICJVSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 50 100 150 200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for JVSA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
JVSA Yearly Profit, Operating, Gross MarginsJVSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

5

2. Health

2.1 Basic Checks

The number of shares outstanding for JVSA has been increased compared to 1 year ago.
Compared to 1 year ago, JVSA has an improved debt to assets ratio.
JVSA Yearly Shares OutstandingJVSA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M
JVSA Yearly Total Debt VS Total AssetsJVSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

JVSA has an Altman-Z score of 111.44. This indicates that JVSA is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 111.44, JVSA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
JVSA has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
JVSA has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. JVSA outperforms 90.20% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 111.44
ROIC/WACCN/A
WACCN/A
JVSA Yearly LT Debt VS Equity VS FCFJVSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

JVSA has a Current Ratio of 1.93. This is a normal value and indicates that JVSA is financially healthy and should not expect problems in meeting its short term obligations.
JVSA's Current ratio of 1.93 is amongst the best of the industry. JVSA outperforms 88.24% of its industry peers.
A Quick Ratio of 1.93 indicates that JVSA should not have too much problems paying its short term obligations.
JVSA has a better Quick ratio (1.93) than 92.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.93
JVSA Yearly Current Assets VS Current LiabilitesJVSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200K 400K 600K 800K

1

3. Growth

3.1 Past

JVSA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2491.30%, which is quite impressive.
EPS 1Y (TTM)2491.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2062.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 41.54, the valuation of JVSA can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as JVSA.
Compared to an average S&P500 Price/Earnings ratio of 26.03, JVSA is valued quite expensively.
Industry RankSector Rank
PE 41.54
Fwd PE N/A
JVSA Price Earnings VS Forward Price EarningsJVSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JVSA Per share dataJVSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for JVSA!.
Industry RankSector Rank
Dividend Yield N/A

JVSPAC ACQUISITION CORP-A

NASDAQ:JVSA (5/21/2025, 8:11:14 PM)

10.8

-0.02 (-0.18%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners86.77%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap83.05M
AnalystsN/A
Price TargetN/A
Short Float %0.04%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 41.54
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.37
P/tB 1.37
EV/EBITDA N/A
EPS(TTM)0.26
EY2.41%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS7.89
TBVpS7.89
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.28%
ROE 3.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.71%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.93
Quick Ratio 1.93
Altman-Z 111.44
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2491.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2062.5%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-949.61%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A